Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.69 Analyst target: $5.57 Upside: 704.33%
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.